In utero or early-life vitamin D deficiency is associated with skeletal problems, type 1 diabetes, and schizophrenia, but the prevalence of vitamin D deficiency in U.S. pregnant women is unexplored. We sought to assess vitamin D status of Higher-dose supplementation is needed to improve maternal and neonatal vitamin D nutriture.
Introduction
Rickets, once thought to have been nearly eradicated in the United States in the 1930s (1) , has again become a major public health problem. Several reports have been published describing recent cases of rickets in infants, most of whom were black and exclusively breastfed (2) (3) (4) (5) . The reemergence of rickets is thought to be due to an epidemic of vitamin D deficiency in mothers and children (6) . A newborn's vitamin D stores are completely reliant on vitamin D from the mother (7) . Not surprisingly, poor maternal vitamin D status during pregnancy is a major risk factor for infant rickets (8) (9) (10) .
In addition to causing poor global mineralization of the skeleton, vitamin D deficiency has implications for numerous other nonskeletal health outcomes. In utero or early life vitamin D deficiency has been linked to an increased risk of type 1 diabetes (11) , asthma (12) , and schizophrenia (13, 14) . Fascinating new data also show that vitamin D regulates placental development and function (15) , which suggests that maternal vitamin D status may be associated with adverse outcomes of pregnancy, such as miscarriage, preeclampsia, and preterm birth.
The most important source of vitamin D is the skin's synthesis of the vitamin from UV B solar radiation (16) . Any process that reduces UV B photons from entering the epidermis will diminish cholecalciferol (vitamin D-3) production. The skin pigment melanin absorbs UV B photons and can reduce vitamin D-3 synthesis by .90% (17) . Consequently, African Americans are at high risk of vitamin D deficiency. The most recent data from the National Health and Nutrition Examination Survey (1988) (1989) (1990) (1991) (1992) (1993) (1994) indicated that vitamin D deficiency [25- hydroxyvitamin D [25(OH)D] #37.5 nmol/L] was prevalent in 42% of black childbearing-aged women and only 4% of white childbearingaged women residing throughout the United States (18) . Vitamin D status is also worsened in winter months (November through March), when, at latitudes above 37°, less UV B radiation reaches the earth and little or no vitamin D can be synthesized in the skin (16, 19) . Indeed, vitamin D deficiency in U.S. childbearing-aged women was more than 3 times as common in winter than summer in both blacks and whites (18) .
Despite the striking racial disparity in vitamin D deficiency and the strong influence of season, there are few recent investigations into the vitamin D status of U.S. black and white pregnant women and their neonates throughout the year. Given the public health importance of adequate vitamin D in this group and the racial disparity in a number of relevant disease outcomes, we sought to assess the vitamin D status of a cohort of nulliparous pregnant women residing in Pittsburgh, Pennsylvania (latitude 40°N) and their neonates by race and season.
Subjects and Methods

Data came from the Pregnancy Exposures and Preeclampsia Prevention
Study (20) . Women carrying singleton fetuses were enrolled at ,16 wk gestation from outpatient clinics at Magee-Women's Hospital in Pittsburgh, Pennsylvania and affiliated private practices from 1997 to 2001. The response rate was 72%. After providing informed, written consent, all subjects completed an interviewer-administered questionnaire at enrollment to collect data on sociodemographic factors, medical history, and health behaviors. Nonfasting blood samples were collected at times of usual blood draws for clinical indications (initial visit, 16-18 wk, 26-29 wk, and predelivery) and banked. Medical records were abstracted to ascertain blood pressures and urinary protein measurements throughout gestation, delivery data, and neonatal outcomes. Venous cord serum samples were also collected and banked. The University of Pittsburgh and Magee-Women's Hospital Institutional Review Boards approved the study.
A total of 2211 women enrolled in the study and had complete data on pregnancy outcomes. For the current analysis, we used SAS random number generator to randomly select 200 white women and 200 black women who were nulliparous (i.e. had no previous pregnancies lasting .20 wk), had no preexisting medical conditions, and had an uncomplicated index pregnancy delivered at term (37-42 wk) with an appropriately grown infant. From each of the 400 women, we sought to select 1 serum sample at ,22 wk gestation, 1 predelivery serum sample, and a cord serum sample. If a woman had more than 1 sample collected at ,22 wk gestation, we randomly selected 1 sample using SAS random number generator. Of the 200 white women selected, 198 had an available banked serum sample collected at ,22 wk, 199 had an available banked serum sample collected predelivery, and 195 had an available banked cord serum sample. These numbers were 194, 185, and 171 for the 200 black women, respectively.
Quantitation of serum 25(OH)D. Maternal and cord serum samples were stored in aliquots at 280°C until they were analyzed for 25(OH)D. Quantitation of serum 25(OH)D was performed using a commercial ELISA from Immunodiagnostic Systems Limited and validated against an HPLC method. The ELISA was performed according to the manufacturer's written protocol and all samples were assayed in duplicate. The ELISA could detect 25(OH)D in the range of 5-300 nmol/L. No sample in our analysis fell outside this detectable range. The interassay CV for the ELISA was 10.3%. The ELISA recognized 100% of 25(OH) D3 and 75% of 25(OH) ergocalciferol (vitamin D-2) but did not distinguish between these 2 forms. In our initial HPLC validation, we observed that only 3 of 32 samples (,10%) had any measurable 25(OH) D2, and within these samples, 25(OH)D2 accounted for only 10% of the total measurable 25(OH)D.
The HPLC method for the quantification of 25(OH)D was modified from those published by Horst et al. (21) and Alvarez and De Mazancourt (22) . Briefly, serum samples were spiked with an internal standard (1 a-hydroxy vitamin D-3 purchased from Sigma) to a final concentration of 50 nmol/L. Samples were processed twice by solid phase extraction, first using C 18 Sep-pak cartridges and then using Silica Sep-pak cartridges. After extraction, samples were dried completely under a nitrogen stream at 37°C and reconstituted in 100% acetonitrile. Fifty microliters of the extracted samples was injected onto a prepared HPLC system that consisted of a Waters 600E pump, a Waters 717 plus autosampler, and a Waters 996 photodiode array. We separated samples on a C18 column (150 3 4.8 mm, 5mm, Supelco) with a 20-3 4.8-mm guard column in line. The HPLC method could separate 1 a-hydroxy vitamin D-3, 25(OH)D2, and 25(OH)D3 using isocratic conditions with a mobile phase that consisted of 87% acetonitrile with all components being detected at a wavelength of 265 nm. For most serum samples, only 25(OH)D3 was detectable. However, a few samples had small but measurable amounts of 25(OH)D2. The interassay CV for 25(OH)D3 using the HPLC method was 5.8%. The sensitivity of the HPLC method was ,10 nmol/L and had a linear range to 1000 nmol/L. (6, 23) . The same cutoffs were used for both women and neonates, because experts contend that there is no reason to think the definition of vitamin D sufficiency varies by age (6).
Race/ethnicity was self-reported as non-Hispanic white or nonHispanic black. Season of sample collection was defined as winter (December, January, February), spring (March, April, May), summer (June, July, August), and fall (September, October, November). Prepregnancy BMI [weight (kg)/height (m) 2 ] was based on measured height and maternal self-report of prepregnancy weight at the initial visit. Self-reported data were available on gravidity (i.e. number of times a woman has been pregnant: 1, 2, $3), marital status (married, unmarried), maternal education (,12, 12, .12 y), and smoking status (smoker, nonsmoker). At enrollment, women self-reported their regular use of multivitamins or prenatal vitamins in the periconceptional period (defined as the 3 mo before and 3 mo after conception), and at delivery, women reported their regular use in the last 3 mo of pregnancy.
Statistical analysis. Nonparametric data were log-transformed before statistical tests were performed. Student's t tests and chi-square tests were used to compare mean 25(OH)D concentrations and proportion of vitamin D deficiency and insufficiency by race/ethnicity. A P-value of 0.05 defined significance. Spearman rank correlation coefficient was used to test for correlations between maternal and cord serum 25(OH)D concentrations. Multivariable regression models were built to assess the independent effect of season on vitamin D status of mothers and newborns. First, we fitted 2 multivariable linear regression models with either maternal or neonatal 25(OH)D concentration as the dependent variable and a series of indicator variables for season as the primary independent variables. Second, we fitted 2 multivariable log-binomial regression models with either maternal or neonatal vitamin D insufficiency (binary) as the dependent variable and season as the primary independent variable. We used generalized estimating equations for both maternal linear and log-binomial models to account for the nonindependence of repeated serum measurements among women (24) .
We fit parsimonious regression models by specifying full models with potential effect modifiers and confounding variables (season, race/ ethnicity, maternal age, education, marital status, gravidity, maternal prepregnancy BMI, smoking status, periconceptional multivitamin use, multivitamin use in the last 3 mo of pregnancy, and sample gestational age). Effect modification by race and blood sample gestational age were tested separately using Wald P-values (a ¼ 0.10). Potential confounders were considered to not be influential and were removed from the model if their inclusion did not satisfy our a priori change-in-estimate criterion (a change in the coefficient of .8%). Sample gestational age, maternal prepregnancy BMI, and periconceptional multivitamin use met our definition of confounding and were included in the final models.
Values in the text are means 6 SEM or mean [95% CI]. Stata software version 8.0 was used for all data analysis.
Results
Black women were more likely than white women to be ,20 y old, unmarried, less educated, nonsmokers, obese, and nonusers of periconceptional multivitamins ( Table 1) . The maternal serum samples were drawn at similar gestational ages in black and white women.
The unadjusted mean maternal serum 25(OH)D concentrations at 4-21 wk gestation and at term were significantly higher among white women than black women ( Table 2) . At 4-21 wk gestation, the vast majority of black women were either vitamin D deficient or insufficient. This is in sharp contrast to white women, almost none of whom were vitamin D deficient at 4-21 wk gestation. However, white women had a high likelihood of vitamin D insufficiency. Results were similar for black and white women in samples collected before delivery (Table 2) . Notably, we observed differences in mean 25 In both racial/ethnic groups, maternal (Fig. 1A) and cord serum (Fig. 1B) 25(OH)D concentrations were highest in summer and lowest in winter and spring (Fig. 1A,B) . However, the amplitude of the difference from winter to summer and spring to summer varied by race/ethnicity. After adjustment for sample gestational age, prepregnancy BMI, and multivitamin use, black women had a smaller mean difference in adjusted maternal 25(OH)D compared with white women from winter to summer (16.0 6 3.3 nmol/L vs. 23.2 6 3.7 nmol/L) and from spring to summer (13.2 6 3.0 nmol/L vs. 27.6 6 4.7 nmol/L). This race-byseason interaction was important (P , 0.01). Similarly, black newborns had a smaller mean adjusted cord blood 25(OH)D increase than white newborns from spring to summer (11.3 6 6.1 nmol/L vs. 29.3 6 4.8 nmol/L, P , 0.05). There were no significant differences in other seasonal contrasts among black and white neonates.
Vitamin D insufficiency in mothers and their neonates was most common in spring among whites and in winter among blacks ( Fig. 2A-C samples (P , 0.001). Compared with summer, the adjusted prevalence of vitamin D insufficiency was 1.9-fold, 2.1-fold, and 1.5-fold in winter, spring, and fall, respectively, among white mothers ( Table 3) . White neonates born in spring had a 76% increased prevalence of vitamin D insufficiency compared with white neonates born in summer. Among black women and newborns, the adjusted prevalence ratios were significantly attenuated compared with those seen in whites and did not show great seasonal variability. Indeed, compared with summer, there was only a 16-21% increase in the likelihood of vitamin D insufficiency in winter, spring, and fall among black women and no significant seasonal effect in black neonates (Table 3) .
Discussion
In this cohort of black and white nulliparous pregnant women with a normal pregnancy outcome who resided in Pittsburgh (latitude 40°N), we found a remarkably high proportion of vitamin D deficiency and insufficiency among mothers throughout gestation and among their infants at birth. Although black women and newborns carried the burden of vitamin D insufficiency, a striking number of white women and their neonates were also affected. Notably, we observed low concentrations of 25(OH)D despite .90% of women reporting regular multivitamin use in the last trimester of pregnancy and 45% reporting regular multivitamin use in the periconceptional period. Studies reporting a high prevalence of vitamin D deficiency among pregnant women and their neonates are abundant, particularly among Middle Eastern women (25) (26) (27) (28) (29) (30) , veiled or deeply pigmented Australians (31), non-Westerners in the Netherlands (32), Athenians (33), and South Asians living in Asia (34,35) , the United Kingdom (36, 37) , and Europe (38, 39 ). Yet, we are aware of only 2 studies that assessed 25(OH)D concentrations in black and white pregnant women in the United States, both of which were conducted over 20 y ago with small sample sizes. In a crosssectional study of 10 black and 12 white pregnant women residing in Cleveland (latitude 41°N) in February and March, investigators reported results consistent with ours: plasma 25(OH)D at term was lower in black mothers (45.5 6 30.3 nmol/L) than white mothers (68.5 6 21.8 nmol/L, P , 0.05) and in black neonates (23.8 6 16.8 nmol/L) than white neonates (37.3 6 13.5 nmol/L, P , 0.05) (7) . In contrast, another study in St. Louis (latitude 38°N) of 56 women in February and 61 women in August found that the mean 3rd-trimester serum 25(OH)D was significantly lower in February (38.5 6 14.8 nmol/L) than August (105 6 34.8 nmol/L) but that there were no differences between black and white women at either time (40) . In a postpartum study of 40 mostly black mother-infant pairs, investigators reported that 50% of mothers had 25(OH)D ,30 nmol/L at 24-48 h postpartum despite a majority of women using a multivitamin during pregnancy (41) . To our knowledge, ours is the first pregnancy study that used the 80-nmol/L cut-point to define vitamin D insufficiency. This cutoff is recommended because it correlates with a number of nutritional biomarkers that are impaired by inadequate vitamin D status (23) . Previous investigators used more conservative cutpoints, which underestimate the magnitude of the problem (23). Similar to other investigators (7, 34, 35, 42) , we found a strong correlation between maternal and cord blood 25(OH)D. Indeed, the high incidence of vitamin D insufficiency in mothers is additionally relevant, because newborns will also have inadequate vitamin D stores to draw on in early life. Although we lacked data on other functional indicators of vitamin D status, such as intact parathyroid hormone, we can assume that when 25(OH)D concentrations are #80 nmol/L, bone mineral density is compromised, and below 37.5 nmol/L, individuals are at risk of osteomalacia or rickets (6) .
The seasonal changes that we observed in 25(OH)D concentrations are well recognized (19, 43, 44) , but few investigators have examined how these seasonal patterns differ between blacks and whites. Our finding of an attenuated increase in mean 25(OH)D and the likelihood of vitamin D insufficiency from winter and spring to summer among black women and black neonates compared with their white counterparts is consistent with 2 studies conducted in U.S. childbearing-aged women (18, 45) and 1 in New Zealand nonpregnant adults (46) . These data support the observation that with typical sunlight exposure, black individuals synthesize less cutaneous vitamin D than do whites (47), leading to an inability of their vitamin D status to recover to adequate levels when sunlight increases in summertime.
Our study was limited by a lack of data on sunlight exposure, dietary vitamin D intake, and skin type/skin pigmentation. Such data would have allowed us to examine the extent to which important determinants of vitamin D status contribute to deficiency in pregnant women and newborns and how they vary by race and season. We also lacked data on the prenatal vitamin brand and dose used by our subjects. Such information would have allowed us to determine whether women were supplemented with vitamin D-2 or vitamin D-3 and the amount they received daily. As mentioned previously, we did not measure functional indicators of maternal or neonatal vitamin D status, such as bone density measurements. Nevertheless, our biracial cohort of 400 mostly low-income women residing at 40°N latitude allowed us to study patterns of 25(OH)D concentrations across seasons. Importantly, our use of the 80-nmol/L cut-point to define vitamin D insufficiency provided the most accurate description of vitamin D nutriture in pregnant women and neonates. Another major strength was the validation of our method of quantifying serum 25(OH)D against HPLC, the gold standard (48) .
Our study suggests that black and white pregnant women residing in northern United States and their neonates are at high risk of vitamin D insufficiency, even when they regularly use a prenatal vitamin or multivitamin. Our data add to the growing body of research supporting assertions that the current vitamin D dietary intake recommendations are inadequate to meet the increased demands of pregnancy (16, 23, 49) . Research into the true vitamin D requirements of pregnancy is greatly needed. With the mounting evidence that vitamin D insufficiency increases the risk of skeletal problems, autoimmune diseases, cancers, type 1 diabetes, heart disease, and schizophrenia (14, 16) , and the striking racial disparities in many of these health outcomes, improving maternal vitamin D status in pregnancy has a tremendous capacity to benefit public health. 
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